Oncology studies often compete for the same small pool of eligible patients. In this example, a sponsor's Phase II study was enrolling below plan after six months.
What we changed
The recovery plan focused on evidence rather than adding more sites.
- Re-ran feasibility using actual screening data from active sites
- Introduced structured pre-screening logs to identify drop-off points
- Held investigator calls to clarify borderline eligibility criteria
- Added referral pathways from nearby community oncology clinics
The outcome
Screen failure rates fell, the enrolment curve returned to plan and the sponsor avoided a costly protocol amendment. Replace this summary with your verified case study figures.
